Viewing StudyNCT05861986



Ignite Creation Date: 2024-05-06 @ 7:01 PM
Last Modification Date: 2024-10-26 @ 2:58 PM
Study NCT ID: NCT05861986
Status: RECRUITING
Last Update Posted: 2024-07-05
First Post: 2023-05-08

Brief Title: A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
Sponsor: Hoffmann-La Roche
Organization: Hoffmann-La Roche

Organization Data

Organization: Hoffmann-La Roche
Class: INDUSTRY
Study ID: BN44620
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Hoffmann-La Roche
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators